Provisio Medical is working to revolutionize endovascular procedures through the
development of Sonic Lumen Tomography (SLT™), a novel intravascular ultrasound
technology that provides accurate and precise real-time flow lumen dimensions.
The SLT platform may also be easily integrated into many of the endovascular
devices that physicians are already using today. Without the shortcomings of the low-resolution angiography’s ionizing radiation and kidney-toxic contrast media, Provisio’s SLT platform looks to seamlessly provide physicians the exact information that they need, when they need it, to improve both clinical workflows and outcomes.
With its SLT technology, Provisio is creating a new paradigm in intravascular
measurements for assessing clinical presentation, guiding treatment decisions
such as proper sizing of therapeutic endovascular devices, and confirming
completion of treatment therapies.
Company’s Keywords:
<17
<
<2014